Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-29 @ 12:15 AM
Study NCT ID:
NCT00918203
Status:
COMPLETED
Last Update Posted:
2019-01-10
First Post:
2009-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-17
Completion Date Type:
ACTUAL
First Submit Date:
2009-06-09
First Submit QC Date:
None
Study First Post Date:
2009-06-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-11-18
Results First Submit QC Date:
None
Results First Post Date:
2017-01-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-05-13
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-12-16
Last Update Post Date:
2019-01-10
Last Update Post Date Type:
ACTUAL